Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy

Maraviroc and JC Virus–Associated Immune Reconstitution Inflammatory Syndrome

(2014) Paul S. Giacomini et al.   NEW ENGLAND JOURNAL OF MEDICINE

Outcome and survival of asymptomatic PML in natalizumab-treated MS patients

(2014) Tuan Dong-Si et al.   Annals of Clinical and Translational Neurology

Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era

(2013) J. L. Casado et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Progressive Multifocal Leukoencephalopathy: Why Gray and White Matter

(2012) Sarah Gheuens et al.   Annual Review of Pathology-Mechanisms of Disease

Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: do protease inhibitors improve survival regardless of central nervous system penetration-effectiveness (CPE) score?

(2012) F Fanjul et al.   HIV MEDICINE

JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy

(2012) Serena Delbue et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?

(2012) C. Antoniol et al.   NEUROLOGY

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

(2012) Gary Bloomgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Progressive multifocal leukoencephalopathy in transplant recipients

(2011) Farrah J. Mateen et al.   ANNALS OF NEUROLOGY

Multiple sclerosis, natalizumab, and PML: Helping patients decide

(2011) R. A. RUDICK   CLEVELAND CLINIC JOURNAL OF MEDICINE

Role of CD4+ and CD8+ T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome

(2011) S. Gheuens et al.   JOURNAL OF VIROLOGY

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

(2011) P. Vermersch et al.   NEUROLOGY

Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy

(2011) Jacques Gasnault et al.   PLoS One

Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis

(2010) S. Belachew et al.   EUROPEAN JOURNAL OF NEUROLOGY

Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy

(2010) M. A. Lima et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Determinants of survival in progressive multifocal leukoencephalopathy

(2009) A. Marzocchetti et al.   NEUROLOGY